(Q43614308)

25 November 2017

title

Co-treatment with As2O3 enhances selective cytotoxic effects of STI-571 against Brc-Abl-positive acute leukemia cells (English)

1 reference

25 November 2017

0 references

1 reference

1 reference

Porosnicu M

1

1 reference

25 November 2017

Nimmanapalli R

2

1 reference

25 November 2017

Nguyen D

3

1 reference

25 November 2017

Worthington E

4

1 reference

25 November 2017

Perkins C

5

1 reference

25 November 2017

Bhalla KN

6

1 reference

25 November 2017

language of work or name

1 reference

1 May 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

15

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

772-778

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402104

25 November 2017

exact match

0 references

cites work

Chronic myelogenous leukemia: biology and therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Activation of p65 NF-kappaB protein by p210BCR-ABL in a myeloid cell line (P210BCR-ABL activates p65 NF-kappaB).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Arsenic trioxide, a novel mitochondriotoxic anticancer agent?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Effects of antisense p21 (WAF1/CIP1/MDA6) expression on the induction of differentiation and drug-mediated apoptosis in human myeloid leukemia cells (HL-60).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Apoptotic pathways: the roads to ruin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Suicidal tendencies: apoptotic cell death by caspase family proteinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Cellular survival: a play in three Akts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Regulation of cell death protease caspase-9 by phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development in erythropoietin receptor-deficient progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402104

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402104

1 reference

Dimensions Publication ID

25 November 2017

1021652249

0 references

1 reference